Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 81 clinical trials
A Pilot Study Using Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy

detecting neuropathy in gastrointestinal cancer patients treated with the chemotherapy drug called a oxaliplatin.

chemotherapy drug
cancer
neuropathy
oxaliplatin
  • 3 views
  • 12 Oct, 2022
  • 1 location
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors

chemotherapy drug Cyclophosphamide.

solid tumour
ewing's sarcoma
cancer chemotherapy
cyclophosphamide
solid tumor
  • 293 views
  • 21 Apr, 2022
  • 6 locations
A Phase II Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

The purpose of this study is to find out whether the study drug, TSR-042, followed by standard chemoradiotherapy (the chemotherapy drug capecitabine + radiation therapy) and standard surgery is

international normalized ratio
direct bilirubin
chemoradiotherapy
serum bilirubin
capecitabine
  • 0 views
  • 24 Oct, 2022
  • 9 locations
A Phase II Multi-Center Trial of Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer

This trial is testing whether a molecularly targeted chemotherapy drug called abemaciclib and an immunotherapy drug called atezolizumab, alone or in combination, are effective in shrinking or

  • 0 views
  • 13 Oct, 2022
  • 1 location
Dendritic Cell/AML Fusion Cell Vaccine Following Allogeneic Transplantation in AML Patients

involved in this study are: Dendritic Cell/AML Fusion vaccine (DC/AML vaccine) Decitabine, a chemotherapy drug

hla-a
blast cells
remission
graft versus host disease
gilbert's syndrome
  • 0 views
  • 16 Feb, 2022
  • 1 location
Randomized, Double-Blinded Phase III Study of Cabozantinib Versus Placebo in Patients With Advanced Neuroendocrine Tumors After Progression on Prior Therapy (CABINET)

(advanced). Cabozantinib is a chemotherapy drug known as a tyrosine kinase inhibitor, and it targets specific tyrosine kinase receptors, that when blocked, may slow tumor growth.

history of allergic reaction
bland embolization
platelet count
somatostatin
selective internal radiation therapy
  • 191 views
  • 27 Oct, 2022
  • 216 locations
Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia

monoclonal antibody, called gemtuzumab, linked to a chemotherapy drug, called ozogamicin. Gemtuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of

remission
monoclonal protein
gilbert's syndrome
induction chemotherapy
acute promyelocytic leukemia
  • 5 views
  • 07 Oct, 2022
  • 1 location
FID-007 in Treating Participants With Advanced Solid Tumors

other places in the body and do not respond to treatment. FID-007 is a packaged form of the chemotherapy drug paclitaxel, and uses a polyethylozaxoline (PEOX) polymer which may allow the drug to reach

serum pregnancy test
neutrophil count
platelet count
body mass index
paclitaxel
  • 37 views
  • 03 Mar, 2022
  • 2 locations
Study of Crizotinib for ROS1 and MET Activated Lung Cancer

chemotherapy drug that is currently approved for the treatment of ALK- or ROS1- positive advanced non-small cell lung cancer.

measurable disease
crizotinib
ROS1
cancer
squamous non-small cell lung cancer
  • 0 views
  • 18 Dec, 2021
  • 1 location
PanDox: Targeted Doxorubicin in Pancreatic Tumours (PanDox)

This study will combine focused ultrasound to generate heat, and a heat-sensitive chemotherapy drug (ThermoDox®), delivered into the blood of participants with non-resectable pancreatic cancer

  • 0 views
  • 14 Mar, 2022
  • 1 location